Human testing of the first anti-nicotine vaccine has begun, according to
British drugs company Xenova. Medical director John Roberts says the drug could
help people quit because it prevents nicotine acting on the brain and so stops
addiction. Nicotine patches or gum simply substitute inhaled nicotine with a
more benign form. The vaccine will work best for smokers who risk relapsing
after quitting. The vaccine will stop a lapse of will power “sending you back to
the beginning of the craving cycle”, says Roberts.
To continue reading, today with our introductory offers
Advertisement
More from New Scientist
Explore the latest news, articles and features
Popular articles
Trending New Scientist articles
1
There’s a been a sudden increase in the rate of sea level rise
2
Fire is spreading in the Chernobyl exclusion zone after drone crash
3
The mathematician who doesn’t exist
4
PCOS postpones perimenopause and allows pregnancies at older ages
5
Red-light therapy does have health benefits but not the ones you think
6
Man destined for Alzheimer's may have been saved by accidental therapy
7
Woman in cancer remission without treatment in highly unusual case
8
Neanderthal 'kneeprint' found next to mysterious stalagmite circle
9
Slow breathing can calm the mind without any need for mindfulness
10
The problem of cosmic inflation and how to solve it
